Control Bionics (ASX:CBL)

Please come by and visit the team Friday to see #DROVE in action!

Happy Occupational Therapist Week! 🎉 Here’s to all the amazing Occupational Therapists empowering lives through care, creativity, and compassion. 🙌 Thanks for everything you do 🤝 #OTWeek #OccupationalTherapy

ATIA’s October 30 webinar unpacks new federal guidance helping to expand access to assistive technology (AT) for children with disabilities. Speakers will share strategies for leveraging this guidance in your work. Register for free at atia.org/webinar

Join us for an interactive event co-hosted by Control Bionics and a panel of experienced speech pathologists working within the NDIS space. Date: 13th of November 2024 at 6-8pm Location: Rooftop at 8 Adolph Street, Cremorne, VIC, 3121 Reserve your spot here: https://lnkd.in/gc7jxybC

Work closely with experienced Occupational Therapists from Better Rehab in an 8 week, part-time research project to assess the world's first autonomous wheelchair module, DROVE. If you would like to learn more, please reach out at lesterl@controlbionics.com.

Control Bionics boosts revenue with faster NDIS approvals and new leasing program https://buff.ly/47T9rZA #ASX #ASX200 $CBL Control Bionics (ASX:CBL)

We're thrilled to announce a significant increase in revenue thanks to faster NDIS approvals. With $1m in the pipeline, we are confident of continued success with the NDIS after securing ~$400k in approvals over the past 8 weeks. This is more than the previous five months combined. 📢 New Launch - Long-term Leasing Program This initiative is for our Trilogy system in Australia, helping those with neurodegenerative conditions access life-changing communication technology faster with a more affordable option. First approvals are in, and we’re excited to roll out this initiative further with our NeuroNode product. 📢 Rights Issue Update We're conducting a pro-rata non-renounceable rights issue to raise up to $2.1 million. The rights issue is underwritten for ~$890,000 and will support the commercialisation of the NeuroStrip, the launch of DROVE, and the expansion of the NeuroNode Only strategy. 📢 Research and Development Tax Incentive We also recently received a Research and Development Tax Incentive of $736,794 for FY24. The debt facility with Radium Capital has now been repaid leaving a residual amount of $288,587. #NDIS #AssistiveTechnology #Neurotech #ControlBionics #ASXnews #Investment #NeuroNode Jeremy Steele Roger Hawke Joe Durak David Falk Kanak Sahasrabudhe Adi Deshpande

I enjoyed sitting down with Paul Sanger and the team at Finance News Network this week to discuss the strong six months Control Bionics (ASX:CBL) has had. We had the chance to talk about our recent success in the US and Europe and the outlook for FY25. We're looking forward to sharing further news in the coming months. https://lnkd.in/gY4VM_fX

Thanks for the coverage Stockhead! Jeremy Steele David Falk Lindsay Phillips Roger Hawke Joe Durak Kanak Sahasrabudhe Adi Deshpande

🎉Big news for Control Bionics! We're excited to announce our exclusive distribution agreement with Smartbox Assistive Technology, the UK’s leading assistive technology provider! This partnership allows us to expand the reach of our innovative NeuroNode® device into the UK and Ireland, empowering people with Motor Neurone Disease (#MND), cerebral palsy, and other neurological disorders. Key highlights: ✅ Exclusive distribution by Smartbox Ltd. ✅ Access to Smartbox’s strong network of healthcare professionals. ✅ Strengthened presence in the European market. We’re confident this partnership will accelerate the adoption of NeuroNode® and improve the quality of life for countless individuals with speech and motor impairments. 💪 #ControlBionics #NeuroNode #AssistiveTechnology #Smartbox #CerebralPalsy #Innovation #UK #Ireland Jeremy Steele Roger Hawke Peter S Ford David Falk Lindsay Phillips Joe Durak Kanak Sahasrabudhe Adi Deshpande